Repligen Corporation
RGEN Healthcare Medical Instruments & Supplies
Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024.
- Revenue
- +10.9%
- EPS
- −351.9%
- Free cash flow
- −11.5%
- Total debt
- +3.28%
Quarter to September 2026, against a year earlier
Follow RGEN
Alert me
Repligen Corporation (RGEN) EV/FCF
As of 5 November 2026, Repligen Corporation (RGEN) trades at a EV/FCF of 166×. Over the past ten years it has ranged from −4,532× (November 2017) to 728× (June 2015); the current reading is higher than 69% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 212× | 158.99% |
| FY2024 | 82.0× | (37.44%) |
| FY2023 | 131× | 25.02% |
| FY2022 | 105× | (65.07%) |
| FY2021 | 300× | 13.12% |
| FY2020 | 265× | 180.20% |
| FY2019 | 94.7× | (18.38%) |
| FY2018 | 116× | (3.42%) |
| FY2017 | 120× | (61.05%) |
| FY2016 | 308× | 346.26% |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 189× | 53.99% |
| Jun 2026 | 123× | 5.21% |
| Mar 2026 | 117× | (44.98%) |
| Dec 2025 | 212× | 61.04% |
| 43 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| SOLV Solventum Corporation compare | 0.0× |
| ALGN Align Technology, Inc. compare | 15.1× |
| BAX Baxter International Inc. compare | 17.5× |
| COO The Cooper Companies, Inc. compare | 21.6× |
| AVTR Avantor, Inc. compare | 30.7× |
| ATR AptarGroup, Inc. compare | 34.9× |
| BLCO Bausch + Lomb Corporation compare | 51.6× |
| RGEN Repligen Corporation | 166× |
| TFX Teleflex Incorporated compare | 172× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on RGEN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement